Literature DB >> 21467999

Rescue from respiratory dysfunction by transduction of full-length dystrophin to diaphragm via the peritoneal cavity in utrophin/dystrophin double knockout mice.

Masatoshi Ishizaki1, Yasushi Maeda, Ryoko Kawano, Tomohiro Suga, Yuji Uchida, Katsuhisa Uchino, Satoshi Yamashita, En Kimura, Makoto Uchino.   

Abstract

Duchenne muscular dystrophy (DMD) is an inherited severe muscle wasting disorder with, thus far, no effective therapy. DMD causes respiratory and cardiac failure as well as muscle wastage. Among the various symptoms, respiratory insufficiency is a major cause of death in DMD patients at about 20 years of age. So, naturally, the improvement of respiratory function will extend the patient's life. We report here, for the first time, a sensitive procedure using whole-body plethysmography to monitor respiratory parameters detected in the utrophin/dystrophin double knockout mouse (dko mouse), showing quite similar systemic symptoms to human DMD including restrictive ventilatory impairment. Furthermore, we show that a highly efficient dystrophin-transduction to the dko's diaphragm--achieved by simple intraperitoneal injection of a helper-dependent adenovirus vector (HDAdv) containing the full-length dystrophin expression cassette--provided beneficial results. In spite of dystrophin expression only in the diaphragm, this focal gene transfer could result in the rescue from ventilatory impairment (increased tidal volume (TV) and improvement of compensatory hyperpnea). Our result suggests that a DMD patient's mortal ventilatory impairment may be improved via technically easy means through the intraperitoneal injection of HDAdv.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21467999      PMCID: PMC3129567          DOI: 10.1038/mt.2011.58

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  29 in total

1.  Failure of early diagnosis in symptomatic Duchenne muscular dystrophy.

Authors:  K M Bushby; A Hill; J G Steele
Journal:  Lancet       Date:  1999-02-13       Impact factor: 79.321

2.  Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy.

Authors:  N Mittereder; K L March; B C Trapnell
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

3.  Dystrophin associated proteins fail in filling dystrophin's shoes.

Authors:  E P Hoffman
Journal:  Nat Genet       Date:  1994-12       Impact factor: 38.330

4.  Dual effects of p38 MAPK on TNF-dependent bronchoconstriction and TNF-independent neutrophil recruitment in lipopolysaccharide-induced acute respiratory distress syndrome.

Authors:  Silvia Schnyder-Candrian; Valerie F J Quesniaux; Franco Di Padova; Isabelle Maillet; Nicolas Noulin; Isabelle Couillin; René Moser; Francois Erard; B Boris Vargaftig; Bernhard Ryffel; Bruno Schnyder
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

5.  Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy.

Authors:  A E Deconinck; J A Rafael; J A Skinner; S C Brown; A C Potter; L Metzinger; D J Watt; J G Dickson; J M Tinsley; K E Davies
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

Review 6.  Utrophin: a potential replacement for dystrophin?

Authors:  J M Tinsley; K E Davies
Journal:  Neuromuscul Disord       Date:  1993 Sep-Nov       Impact factor: 4.296

7.  The alternative carboxyl termini of avian cardiac and brain sarcoplasmic reticulum/endoplasmic reticulum Ca(2+)-ATPases are on opposite sides of the membrane.

Authors:  A M Campbell; P D Kessler; D M Fambrough
Journal:  J Biol Chem       Date:  1992-05-05       Impact factor: 5.157

8.  The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein.

Authors:  M Koenig; A P Monaco; L M Kunkel
Journal:  Cell       Date:  1988-04-22       Impact factor: 41.582

9.  The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle.

Authors:  E E Zubrzycka-Gaarn; D E Bulman; G Karpati; A H Burghes; B Belfall; H J Klamut; J Talbot; R S Hodges; P N Ray; R G Worton
Journal:  Nature       Date:  1988-06-02       Impact factor: 49.962

10.  Systemic administration of endotoxin induces bronchopulmonary hyperreactivity dissociated from TNF-alpha formation and neutrophil sequestration into the murine lungs.

Authors:  J Lefort; M Singer; D Leduc; P Renesto; M A Nahori; M Huerre; C Créminon; M Chignard; B B Vargaftig
Journal:  J Immunol       Date:  1998-07-01       Impact factor: 5.422

View more
  5 in total

1.  Engraftment of ES-Derived Myogenic Progenitors in a Severe Mouse Model of Muscular Dystrophy.

Authors:  Antonio Filareto; Radbod Darabi; Rita C R Perlingeiro
Journal:  J Stem Cell Res Ther       Date:  2012-01-06

2.  Implications for Cardiac Function Following Rescue of the Dystrophic Diaphragm in a Mouse Model of Duchenne Muscular Dystrophy.

Authors:  Corinne A Betts; Amer F Saleh; Carolyn A Carr; Sofia Muses; Kim E Wells; Suzan M Hammond; Caroline Godfrey; Graham McClorey; Caroline Woffindale; Kieran Clarke; Dominic J Wells; Michael J Gait; Matthew J A Wood
Journal:  Sci Rep       Date:  2015-06-26       Impact factor: 4.379

Review 3.  Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy.

Authors:  Joe W McGreevy; Chady H Hakim; Mark A McIntosh; Dongsheng Duan
Journal:  Dis Model Mech       Date:  2015-03       Impact factor: 5.758

4.  CXCL12 and osteopontin from bone marrow-derived mesenchymal stromal cells improve muscle regeneration.

Authors:  Yasushi Maeda; Yasuhiro Yonemochi; Yuki Nakajyo; Hideaki Hidaka; Tokunori Ikeda; Yukio Ando
Journal:  Sci Rep       Date:  2017-06-12       Impact factor: 4.379

Review 5.  High-Capacity Adenoviral Vectors: Expanding the Scope of Gene Therapy.

Authors:  Ana Ricobaraza; Manuela Gonzalez-Aparicio; Lucia Mora-Jimenez; Sara Lumbreras; Ruben Hernandez-Alcoceba
Journal:  Int J Mol Sci       Date:  2020-05-21       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.